000166039 001__ 166039
000166039 005__ 20240229123219.0
000166039 0247_ $$2doi$$a10.1016/j.canep.2020.101858
000166039 0247_ $$2pmid$$apmid:33246249
000166039 0247_ $$2ISSN$$a1877-7821
000166039 0247_ $$2ISSN$$a1877-783X
000166039 0247_ $$2altmetric$$aaltmetric:95253757
000166039 037__ $$aDKFZ-2020-02578
000166039 041__ $$aeng
000166039 082__ $$a610
000166039 1001_ $$0P:(DE-He78)a79a61dd9934f6115f9383fd1dc21d76$$aFinke, Isabelle$$b0$$eFirst author
000166039 245__ $$aEducational inequalities and regional variation in colorectal cancer survival in Finland.
000166039 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2021
000166039 3367_ $$2DRIVER$$aarticle
000166039 3367_ $$2DataCite$$aOutput Types/Journal article
000166039 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1627903276_25573
000166039 3367_ $$2BibTeX$$aARTICLE
000166039 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000166039 3367_ $$00$$2EndNote$$aJournal Article
000166039 500__ $$a#EA:C070#
000166039 520__ $$aPrevious studies have reported lower colorectal cancer (CRC) survival in patients with low compared to high educational levels. We investigated the impact of education on CRC survival by using both individual and area-based information on education.Patients diagnosed with CRC in Finland in 2007-2016 were followed up for death until the end of 2016. Age-standardized relative survival and relative excess risk of death (RER) were estimated by sex using period approach. RERs were adjusted for age, stage at diagnosis, cancer site, urbanity, hospital district and municipality by using Bayesian piecewise constant excess hazard models. Analyses were conducted including individual (basic, secondary, high) and area-based (quartiles Q1-Q4 based on the proportion of population with basic education) education separately as well as both measures in one model.We analysed in all 24 462 CRC patients. There was a clear gradient in 5-year relative survival across education groups (men: basic 62 %, secondary 64 %, high 69 %; women: basic 61 %, secondary 67 %, high 71 %). Compared to the basic education group, RER in the high education group was significantly lower. This association was still present after including area-based education in the models (men: RER 0.72, 95 % Confidence interval (CI) 0.64-0.81; women: RER 0.76, 95 % CI 0.59-0.96). Area-based education revealed smaller effect estimates than individual education in CRC survival and no association for men.Individual education information should be preferred over area-based when survival differences are studied by education. Educational differences in CRC survival are still present in Finland.
000166039 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000166039 588__ $$aDataset connected to CrossRef, PubMed,
000166039 7001_ $$aSeppä, Karri$$b1
000166039 7001_ $$aMalila, Nea$$b2
000166039 7001_ $$0P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aJansen, Lina$$b3
000166039 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b4
000166039 7001_ $$aPitkäniemi, Janne$$b5
000166039 773__ $$0PERI:(DE-600)2498032-8$$a10.1016/j.canep.2020.101858$$gVol. 70, p. 101858 -$$p101858$$tCancer epidemiology$$v70$$x1877-7821$$y2021
000166039 909CO $$ooai:inrepo02.dkfz.de:166039$$pVDB
000166039 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a79a61dd9934f6115f9383fd1dc21d76$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000166039 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000166039 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000166039 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000166039 9141_ $$y2020
000166039 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER EPIDEMIOL : 2018$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-18
000166039 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-08-18
000166039 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000166039 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000166039 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000166039 980__ $$ajournal
000166039 980__ $$aVDB
000166039 980__ $$aI:(DE-He78)C070-20160331
000166039 980__ $$aI:(DE-He78)C120-20160331
000166039 980__ $$aI:(DE-He78)HD01-20160331
000166039 980__ $$aUNRESTRICTED